annual cash & cash equivalents:
$124.12M+$23.98M(+23.94%)Summary
- As of today (July 11, 2025), ELVN annual cash & cash equivalents is $124.12 million, with the most recent change of +$23.98 million (+23.94%) on December 31, 2024.
- During the last 3 years, ELVN annual cash & cash equivalents has risen by +$14.09 million (+12.81%).
- ELVN annual cash & cash equivalents is now -4.79% below its all-time high of $130.37 million, reached on December 1, 2020.
Performance
ELVN Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$101.70M-$22.41M(-18.06%)Summary
- As of today (July 11, 2025), ELVN quarterly cash & cash equivalents is $101.70 million, with the most recent change of -$22.41 million (-18.06%) on March 31, 2025.
- Over the past year, ELVN quarterly cash & cash equivalents has dropped by -$47.46 million (-31.82%).
- ELVN quarterly cash & cash equivalents is now -65.18% below its all-time high of $292.10 million, reached on March 31, 2023.
Performance
ELVN quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ELVN Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.9% | -31.8% |
| 3 y3 years | +12.8% | - |
| 5 y5 years | -4.8% | -7.6% |
ELVN Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.3% | -65.2% | +37.7% |
| 5 y | 5-year | -4.8% | +64.3% | -65.2% | +37.7% |
| alltime | all time | -4.8% | +64.3% | -65.2% | +37.7% |
ELVN Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $101.70M(-18.1%) |
| Dec 2024 | $124.12M(+23.9%) | $124.12M(+23.4%) |
| Sep 2024 | - | $100.62M(+3.9%) |
| Jun 2024 | - | $96.87M(-35.1%) |
| Mar 2024 | - | $149.16M(+49.0%) |
| Dec 2023 | $100.14M | $100.14M(+35.6%) |
| Sep 2023 | - | $73.85M(-41.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $125.72M(-57.0%) |
| Mar 2023 | - | $292.10M(+286.7%) |
| Dec 2022 | $75.54M(-31.3%) | $75.54M(-12.3%) |
| Sep 2022 | - | $86.16M(-21.7%) |
| Dec 2021 | $110.02M(-15.6%) | - |
| Dec 2021 | - | $110.02M |
| Dec 2020 | $130.37M | - |
FAQ
- What is Enliven Therapeutics, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is Enliven Therapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of ELVN is $124.12M
What is the all time high annual cash & cash equivalents for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual cash & cash equivalents is $130.37M
What is Enliven Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, ELVN annual cash & cash equivalents has changed by +$23.98M (+23.94%)
What is Enliven Therapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ELVN is $101.70M
What is the all time high quarterly cash & cash equivalents for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $292.10M
What is Enliven Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, ELVN quarterly cash & cash equivalents has changed by -$47.46M (-31.82%)